Results 191 to 200 of about 16,632 (221)
Some of the next articles are maybe not open access.

Droxidopa for neurogenic orthostatic hypotension

Expert Opinion on Orphan Drugs, 2015
Introduction: Neurogenic orthostatic hypotension is a disabling manifestation of autonomic failure seen in disorders such as multiple system atrophy, pure autonomic failure, Lewy body disease, Parkinson’s disease, autonomic neuropathies and dopamine β-hydroxylase deficiency.Areas covered: Droxidopa is an orally administered norepinephrine prodrug that ...
openaire   +1 more source

Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension

CNS Drugs, 2017
Neurogenic orthostatic hypotension (NOH) can be present in a number of disorders, including synucleinopathies, autoimmune disorders, and various genetic disorders. All are characterized by defective norepinephrine release from sympathetic terminals upon standing, resulting in impaired vasoconstriction.
Jacquie, Baker, Kurt, Kimpinski
openaire   +2 more sources

Droxidopa approved for neurogenic orthostatic hypotension

American Journal of Health-System Pharmacy, 2014
Droxidopa, a synthetic amino acid precursor of norepinephrine, has been approved as oral therapy for the treatment of neurogenic orthostatic hypotension, FDA and Chelsea Therapeutics announced on February 18.
openaire   +1 more source

Baroreflex-sympathoneural without baroreflex-cardiovagal failure in neurogenic orthostatic hypotension

Clinical Autonomic Research, 2023
D. Goldstein   +4 more
semanticscholar   +1 more source

A case showing how hyperventilation may decrease blood pressure in neurogenic orthostatic hypotension

Clinical Autonomic Research, 2023
J. V. van Dijk   +6 more
semanticscholar   +1 more source

Efficacy of Midodrine for Neurogenic Orthostatic Hypotension

JAMA: The Journal of the American Medical Association, 1997
To the Editor. —Orthostatic hypotension due to autonomic failure is an incapacitating condition for which treatment, despite various drug interventions (eg, yohimbine, metoclopramide, β-blockers, somatostatin analog) is not yet resolved. Therefore, the encouraging results of the study of Dr Low and colleagues 1 are potentially of great importance ...
openaire   +1 more source

Mechanisms underlying unawareness of neurogenic orthostatic hypotension

Clinical Autonomic Research, 2020
Philip W, Tipton, William P, Cheshire
openaire   +2 more sources

Precision therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy

medRxiv
Roy Freeman   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy